Drug Type Small molecule drug |
Synonyms Telmisartan/azelnidipine |
Mechanism AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), L-type calcium channel blockers(Voltage-gated L-type calcium channel blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |
Molecular FormulaC33H30N4O2 |
InChIKeyRMMXLENWKUUMAY-UHFFFAOYSA-N |
CAS Registry144701-48-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hypertension | Phase 2 | IN | 28 Dec 2019 |